TSC2

Revision as of 15:22, 6 September 2012 by WikiBot (talk | contribs) (Robot: Automated text replacement (-{{reflist}} +{{reflist|2}}, -<references /> +{{reflist|2}}, -{{WikiDoc Cardiology Network Infobox}} +))
Jump to navigation Jump to search

Template:PBB

WikiDoc Resources for TSC2

Articles

Most recent articles on TSC2

Most cited articles on TSC2

Review articles on TSC2

Articles on TSC2 in N Eng J Med, Lancet, BMJ

Media

Powerpoint slides on TSC2

Images of TSC2

Photos of TSC2

Podcasts & MP3s on TSC2

Videos on TSC2

Evidence Based Medicine

Cochrane Collaboration on TSC2

Bandolier on TSC2

TRIP on TSC2

Clinical Trials

Ongoing Trials on TSC2 at Clinical Trials.gov

Trial results on TSC2

Clinical Trials on TSC2 at Google

Guidelines / Policies / Govt

US National Guidelines Clearinghouse on TSC2

NICE Guidance on TSC2

NHS PRODIGY Guidance

FDA on TSC2

CDC on TSC2

Books

Books on TSC2

News

TSC2 in the news

Be alerted to news on TSC2

News trends on TSC2

Commentary

Blogs on TSC2

Definitions

Definitions of TSC2

Patient Resources / Community

Patient resources on TSC2

Discussion groups on TSC2

Patient Handouts on TSC2

Directions to Hospitals Treating TSC2

Risk calculators and risk factors for TSC2

Healthcare Provider Resources

Symptoms of TSC2

Causes & Risk Factors for TSC2

Diagnostic studies for TSC2

Treatment of TSC2

Continuing Medical Education (CME)

CME Programs on TSC2

International

TSC2 en Espanol

TSC2 en Francais

Business

TSC2 in the Marketplace

Patents on TSC2

Experimental / Informatics

List of terms related to TSC2


Tuberous sclerosis protein 2, also known as TSC2 and Tuberin, is a human protein and gene.

Mutations in this gene lead to tuberous sclerosis. Its gene product is believed to be a tumor suppressor and is able to stimulate specific GTPases. The protein associates with hamartin in a cytosolic complex, possibly acting as a chaperone for hamartin. Alternative splicing results in multiple transcript variants encoding different isoforms of the protein.[1]

References

  1. "Entrez Gene: TSC2 tuberous sclerosis 2".

Further reading

  • Jones AC, Shyamsundar MM, Thomas MW; et al. (1999). "Comprehensive mutation analysis of TSC1 and TSC2-and phenotypic correlations in 150 families with tuberous sclerosis". Am. J. Hum. Genet. 64 (5): 1305–15. PMID 10205261.
  • Hengstschläger M (2002). "Tuberous sclerosis complex genes: from flies to human genetics". Arch. Dermatol. Res. 293 (8): 383–6. PMID 11686512.
  • Hockenbery DM (2003). "Nailing down a link between tuberin and renal cysts". Am. J. Pathol. 162 (2): 369–71. PMID 12547695.
  • Ramesh V (2004). "Aspects of tuberous sclerosis complex (TSC) protein function in the brain". Biochem. Soc. Trans. 31 (Pt 3): 579–83. doi:10.1042/ Check |doi= value (help). PMID 12773159.
  • Knowles MA, Hornigold N, Pitt E (2004). "Tuberous sclerosis complex (TSC) gene involvement in sporadic tumours". Biochem. Soc. Trans. 31 (Pt 3): 597–602. doi:10.1042/ Check |doi= value (help). PMID 12773163.
  • Ellisen LW (2007). "Growth control under stress: mTOR regulation through the REDD1-TSC pathway". Cell Cycle. 4 (11): 1500–02. PMID 16258273.
  • Jozwiak J, Jozwiak S (2007). "Giant cells: contradiction to two-hit model of tuber formation?". Cell. Mol. Neurobiol. 27 (2): 251–61. doi:10.1007/s10571-006-9106-0. PMID 16897363.
  • Cai SL, Walker CL (2007). "TSC2, a key player in tumor suppression and cystic kidney disease". Nephrol. Ther. 2 Suppl 2: S119–22. PMID 17373211.
  • Urban T (2007). "[Pulmonary lymphangioleiomyomatosis with or without tuberous sclerosis]". Revue des maladies respiratoires. 24 (6): 725–40. PMID 17632432.

Template:WH Template:WS